USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: NANOMETICS, LLC
City: NEW YORK
State: NY
Zip+4: 10003-6502
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $494,009.00 2
SBIR Phase II $2,595,637.00 1

Award List:

Organocatalysis for the Treatment of Sickle Cell Disease.

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Steven Isaacman – 646-267-5720
Award Amount: $243,469.00
Abstract:
DESCRIPTION (provided by applicant): One potential therapeutic approach to treat sickle cell disease (SCD) involves the administration of aryl aldehyde-containing small molecules that form Schiff base adducts with hemoglobin (HbS) and prevent sickling. Theutility of this approach is inherently… More

Schiff base forming sunscreen filters for long-wear UV protection

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Steven Isaacman – 646-267-5720
Award Amount: $250,540.00
Abstract:
DESCRIPTION (provided by applicant): Problem to be solved: Skin cancer is the most common of all cancers, accounting for nearly half of all reported cancer cases in the USA. According to the American Cancer Society (ACS), the best way to lower the risk ofnon-melanoma skin cancer is to practice sun… More

Organocatalysis for the treatment of sickle cell disease

Award Year / Program / Phase: 2013 / SBIR / Phase II
Agency: HHS
Principal Investigator: Steven Isaacman – 646-801-3872
Award Amount: $2,595,637.00
Abstract:
DESCRIPTION (provided by applicant): Sickle cell disease (SCD) is a global health issue that affects ~100,000 Americans and over 13 million people worldwide. The complexity of the disease dictates that a multimodal approach to treatment will likely be needed. SCD is manifested physiologically during… More